Rochester Drug Co-Op Sues Reckitt Over Heroin Treatment
This article is for subscribers only.
Rochester Drug Co-Operative Inc., a distributor of generic drugs, sued U.K. pharmaceutical maker Reckitt Benckiser Group Plc for allegedly monopolizing the market for heroin treatment.
Reckitt developed a sublingual strip version of its Suboxone anti-addiction drug to replace the tablet form, Rochester Drug said in its lawsuit, filed today in U.S. District Court in Wilmington, Delaware. This prevented competition because pharmacists wouldn’t be allowed to substitute the cheaper generic version, according to Rochester Drug’s lawsuit.